ADPT R&D to Revenue
Adaptive Biotechnologies Corp · R&D to Revenue
ADPT R&D to Revenue
Latest reported33.85%period ending
ADPT FY R&D/Revenue (83.22% → 33.85%)
Latest values, visible window
High-resolution chart · PNG
ADPT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 33.8546% | |
| 57.5295% | |
| 71.7171% | |
| 76.4975% | |
| 92.2245% | |
| 117.9809% | |
| 83.1129% | |
| 70.3465% | |
| 83.2163% |